MATINAS BIOPHARMA HOLDINGS, INC. Retained Earnings
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Retained Earnings of -$214.03 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-13
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$214.03M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$212.71M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$210.79M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$208.88M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$214.03M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$212.71M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | -$210.79M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$208.88M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$206.72M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$201.48M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$199.82M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$191.39M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | -$187.12M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$181.40M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$175.57M 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$170.26M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$164.20M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$158.14M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$152.63M 10-K · filed 2024-03-27 | |
| 2022-09-30 | -$149.00M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$143.54M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$137.61M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$131.63M 10-K · filed 2023-03-15 | -$131.63M 10-K · filed 2022-03-08 |
| 2021-09-30 | -$124.93M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | -$118.10M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | -$112.46M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | -$107.51M 10-K/A · filed 2022-03-11 | |
| 2020-09-30 | -$101.17M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | -$95.72M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$89.42M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$84.38M 10-K · filed 2021-03-29 | |
| 2019-09-30 | -$78.80M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | -$73.81M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$70.00M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | -$65.94M 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$62.32M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$58.80M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$55.38M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$51.27M 10-K · filed 2019-04-01 | |
| 2017-09-30 | -$47.65M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $43.64M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | -$39.68M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$35.18M 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$33.29M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$27.06M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$25.43M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$23.19M 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$21.18M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | -$19.03M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | -$16.62M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | -$14.05M 10-K · filed 2016-03-30 | |
| 2014-09-30 | -$11.01M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$8.40M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | -$5.97M 10-Q · filed 2014-06-06 | |
| 2013-12-31 | -$3.83M 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |